Pfizer earning details analysis and thoughts
@Just Do It:
Pharmaceutical giant Pfizer Inc. reported its first quarter 2023 results before the market on Tuesday, May 2, reporting revenue of $18.28 billion for the quarter, still beating previous estimates, despite a sharp decline in revenue related to new crowns. I. Company Profile Pfizer is an international pharmaceutical giant dedicated to the development of healthcare products, with specific businesses in pharmaceuticals, vaccines and consumer health. Second, financial analysis: the period of epidemic windfall passed, revenue and net profit dropped sharply, but better than expected On the revenue side, Pfizer's revenue for the first quarter was $18.28 billion, down 28.8% year-over-year, exceeding previous estimates of $16.6 billion. Pfizer's current revenue composition can be divided into three